Selank

What is Selank?

Selank is a synthetic analog of tuftsin — a naturally occurring immunomodulatory tetrapeptide — extended with a Pro-Gly-Pro sequence to improve stability and CNS penetration. Like Semax, it was developed at the Russian Academy of Sciences and has been an approved pharmaceutical in Russia for decades, used clinically for anxiety disorders, neurasthenia, and cognitive impairment. That 30-year track record of pharmaceutical-grade use is the most meaningful evidence of its safety profile — not a handful of Western trials, but decades of real-world medical use.

Selank's core value proposition is anxiety reduction without the trade-offs of conventional anxiolytics. Benzodiazepines are effective but produce sedation, cognitive impairment, and physical dependence. SSRIs take weeks to work and have sexual side effects and emotional blunting. Selank reduces anxiety acutely — effects within 30–60 minutes of intranasal administration — without sedation, without dependence, without impairing cognition. In fact, it often improves cognitive function alongside anxiety reduction, which is mechanistically consistent with its BDNF upregulation and serotonin system modulation.

In biohacker communities, Selank is almost always discussed alongside Semax — the 'Semax + Selank cognitive stack' is the canonical nootropic peptide combination. Semax provides the cognitive sharpening and motivation enhancement via BDNF and melanocortin receptor effects. Selank provides the anxiety reduction and emotional stability that allows the Semax-enhanced focus to be clean and functional rather than anxious. They complement each other precisely because they target different aspects of cognitive performance.

The immunomodulatory effects of Selank — inherited from its tuftsin parent — are genuinely interesting and underappreciated. Tuftsin activates natural killer cells and macrophages; Selank appears to modulate IL-6, IL-1, and TNF-α production. Russian clinical trials in HIV-positive patients showed Selank improving immune parameters. This immune effect is not why most biohackers use it, but it adds a layer of biological interest beyond the anxiolytic mechanism.

How it works

GABAergic Modulation — Without Benzodiazepine Dependence

Selank's primary anxiolytic mechanism involves modulation of GABA-A receptors — the same receptor system that benzodiazepines act on, but through a different mechanism. Rather than directly binding the benzodiazepine site (which produces sedation and dependence), Selank modulates GABA-A receptor expression and sensitivity in a more physiological way. This produces anxiolytic effects without the sedation or receptor downregulation (tolerance) associated with direct GABA-A agonism.

Serotonin System Modulation

Selank increases serotonin metabolism and regulates serotonin transporter (SERT) expression. This serotonergic effect contributes to mood stabilization and the anxiolytic profile — and is distinct from SSRI mechanisms, which block reuptake acutely. Selank's modulation of serotonin turnover is more nuanced and faster-acting than SSRI-class antidepressants. This also means it has unpredictable interaction potential with serotonergic medications.

BDNF Upregulation

Like Semax, Selank upregulates BDNF (brain-derived neurotrophic factor) in the hippocampus and frontal cortex. BDNF supports synaptic plasticity, neuronal survival, and the formation of new neural connections. This BDNF effect underlies Selank's nootropic properties and its potential long-term neuroprotective effects beyond acute anxiolytic action.

Enkephalin System and Immunomodulation

Selank modulates enkephalin degradation, increasing the availability of endogenous opioid peptides that regulate mood, pain perception, and stress responses — contributing to mild mood-lifting and stress-buffering effects. Via its tuftsin-derived structure, it also modulates natural killer cell activity, macrophage function, and cytokine production (IL-6, IL-1, TNF-α), providing the immunomodulatory dimension investigated in HIV and immunocompromised populations.

What the research shows

What the community reports

Selank's community is primarily nootropic-focused — people who care about cognitive performance, anxiety management without sedation, and the Semax + Selank stack. The reports are unusually consistent and described with more nuance than many peptides, probably because the community skews toward cognitively-oriented biohackers who track their subjective states carefully.

The no-dependence profile is what drives loyalty in the Selank community. Users who have dealt with benzodiazepine dependence or SSRI discontinuation syndrome find Selank's on-demand, clean anxiolytic effect genuinely liberating. That practical distinction from conventional anxiolytics is the compound's most significant community-reported advantage.

Common misconceptions